CXCR4 agonist treatment of hematopoietic cells

Details for Australian Patent Application No. 2005201244 (hide)

Owner Chemokine Therapeutics Corporation The University of British Columbia

Inventors Lakhdar, Arab; Clark-Lewis, Ian; Merzouk, Ahmed; Tudan, Christopher R.; Cashman, Johanne; Saxena, Geeta; Eaves, Connie J.; Salari, Hassan

Agent Spruson & Ferguson

Pub. Number AU-B-2005201244

Parent 2001252081

Filing date 22 March 2005

Wipo publication date 7 April 2005

Acceptance publication date 1 February 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

7 April 2005 Application Open to Public Inspection

  Published as AU-B-2005201244

7 April 2005 Complete Application Filed

1 February 2007 Application Accepted

  Published as AU-B-2005201244

31 May 2007 Standard Patent Sealed

1 April 2010 Alteration of Name

  The name of the patentee has been altered to The University of British Columbia; British Canadian Biosciences Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201245-Swimming Goggles

2005201243-Increasing brain glucose utilisation